Supernus Pharmaceuticals, Inc. · NASDAQ:SUPN

Armistice Capital, LLC reported a 8.76% stake in Supernus Pharmaceuticals, Inc. (Schedule 13G/A)

Event Dec 31, 2024 · Filed Feb 14, 2025

Armistice Capital, LLC reported a 8.76% stake in Supernus Pharmaceuticals, Inc., 4,836,000 shares, as a passive investor on Dec 31, 2024. Filed Feb 14, 2025 (Schedule 13G/A).

Stake
8.76%
Shares
4,836,000
Intent
Passive
What changed
Stake changed
Filed together
2 holders

The filing in full

HolderStakeShares
Armistice Capital, LLC8.76%4,836,000
Steven Boyd8.76%4,836,000

Source

View original at SEC

Related